Effects of GSK3 Inhibitors on Human Stem Cells
Author Information
Author(s): Zaragosi Laure-Emmanuelle, Wdziekonski Brigitte, Fontaine Coralie, Villageois Phi, Peraldi Pascal, Dani Christian
Primary Institution: Institute of Signalling, Biology of Development and Cancer, University of Nice Sophia-Antipolis
Hypothesis
Can GSK3 inhibitors regulate the proliferation and differentiation of human adipose-derived stem cells into adipocytes?
Conclusion
GSK3 inhibitors can effectively regulate the function of adipose-derived stem cells, suggesting their potential as therapeutic targets.
Supporting Evidence
- GSK3 inhibitors inhibited the proliferation of human stem cells.
- Adipogenic and osteogenic differentiations were inhibited by GSK3 inhibitors.
- A chronic treatment was required to inhibit osteogenesis, while early treatment was sufficient to inhibit adipogenesis.
Takeaway
This study found that certain drugs can stop fat stem cells from growing and turning into fat cells, which might help treat obesity.
Methodology
The study involved treating human adipose-derived stem cells with GSK3 inhibitors and measuring their proliferation and differentiation.
Limitations
The study does not address potential adverse effects of GSK3 inhibitors on other signaling pathways.
Participant Demographics
Stem cells were derived from human adipose tissue of a 5-year-old and a 4-month-old male donor.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website